Compare IDYA & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | KLIC |
|---|---|---|
| Founded | 2015 | 1951 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.3B |
| IPO Year | 2019 | 2004 |
| Metric | IDYA | KLIC |
|---|---|---|
| Price | $31.40 | $61.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 3 |
| Target Price | $51.21 | ★ $54.67 |
| AVG Volume (30 Days) | ★ 824.6K | 499.4K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.27% |
| EPS Growth | 61.90 | ★ 100.32 |
| EPS | N/A | ★ 0.32 |
| Revenue | $218,710,000.00 | ★ $654,081,000.00 |
| Revenue This Year | N/A | $45.04 |
| Revenue Next Year | $191.08 | $11.95 |
| P/E Ratio | ★ N/A | $202.31 |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $13.45 | $26.63 |
| 52 Week High | $39.28 | $77.50 |
| Indicator | IDYA | KLIC |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 41.61 |
| Support Level | $29.15 | $61.28 |
| Resistance Level | $35.47 | $72.90 |
| Average True Range (ATR) | 1.47 | 2.72 |
| MACD | -0.26 | -0.43 |
| Stochastic Oscillator | 30.38 | 3.44 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Kulicke & Soffa Industries Inc. is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments, which include Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.